Initial visitors to Sin City following coronavirus shutdowns may feel like they hit a jackpot before they even board a plane. Some Las Vegas casino resorts reopened last week after Nevada lifted coronavirus restrictions that had been in place since late March. Travelers looking to book a room were greeted by an array of deals […] …read more […]
Will a single antibody be enough to stomp out a COVID-19 infection? Sorrento Therapeutics (SRNE) says no. Rather, the company believes that an antibody cocktail could be capable of providing protection against a SARS-CoV-2 coronavirus infection, with the cocktail remaining effective should the virus mutate.To find the select few with the ability to block the S1 protein’s interaction with human angiotensin-converting enzyme 2 (ACE2), the receptor used for viral entrance into human cells, SRNE assessed billions of antibodies. Now, after announcing yet another monoclonal antibody (MaB), STI-4938 (COVIDTRAP), was able to inhibit SARS-CoV-2 viral infection in vitro, some members of …read more […]
TD Ameritrade Trader Strategy Manager Shawn Cruz joins Yahoo Finance’s On The Move to address what stocks investors are buying amid market volatility. …read more […]
U.S. President Donald Trump decided to withdraw thousands of troops from Germany. Meanwhile, European markets opened lower on Monday, as new data showed German factories suffered their steepest decline in production on record in April. Yahoo Finance’s Tom Belger weighs in. …read more […]
Casino stocks skyrocket upon Las Vegas reopening and airlines add flights as demand increases. Yahoo Finance’s On The Move panel shares the details. …read more […]
(Bloomberg) — Saudi Arabia’s extra voluntary oil-production cut, which came on top of the OPEC+ supply curbs, will cease at the end of this month as demand recovers.Crude prices erased gains as Energy Minister Prince Abdulaziz bin Salman said the kingdom’s additional reductions, which amounted to about 1.2 million barrels a day including contributions from its closest allies in the Persian Gulf, will only take effect in June as planned.That means the cartel’s total supply reduction this month of almost 11 million barrels a day will taper gradually in the coming months.“The voluntary cuts served their purpose and we are …read more […]
Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Dan Howley discuss the backlash Mark Zuckerberg is facing amid civil unrest. …read more […]
Winnie Sun, Sun Group Wealth Partners, joins Yahoo Finance’s The First Trade to discuss where her clients are investing, including technology in the long-term, savings, travel and more. …read more […]
Diamond Hill Capital recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Diamond Hill Small Cap Fund posted a return of -36.17% for the quarter, underperforming its benchmark, the Russell 2000 Index which returned -30.61% in the same quarter. You should check out Diamond Hill Capital’s top 5 […] …read more […]
Narayana Kocherlakota, Former Minneapolis Fed President, joins Yahoo Finance’s Brian Cheung, Brian Sozzi and Alexis Christoforous to discuss what we can expect from the Federal Reserve in the coming weeks. …read more […]
An editor at both the New York Times and Philadelphia Inquirer chose to resign after facing backlash over controversial headlines. Yahoo Finance’s Emily McCormick breaks down the details. …read more […]
Arguably the most controversial on the Street, penny stocks are a hot-button issue. Usually, there isn’t a lot of middle-ground with respect to these tickers priced for less than $5 apiece. Dividing market watchers into two distinct groups, both sides present valid arguments laying out the pros and cons.Sure, there is reason enough to be skeptical. Often, a cheap stock is cheap for a reason, with the low share price potentially reflecting an underlying problem with the business, whether it be poor fundamentals or unbeatable headwinds. That said, a bargain price tag isn’t always indicative of a lost cause. …read more […]
(Bloomberg) — Data on Sarepta Therapeutics Inc.’s experimental gene therapy for a rare type of muscular dystrophy showed that patients receiving a higher dose of the medicine saw greater benefits than those receiving a lower dose, delivering another early-stage win for the drug developer.Three patients with limb-girdle muscular dystrophy Type 2E who got the high dose of Sarepta’s SRP-9003 produced greater levels of the protein beta-sarcoglycan. While patients with the progressive and debilitating muscle-wasting disease normally make very little or none of the protein, the three children showed an average protein expression that was 62% of normal, topping 36% seen …read more […]
Reebok decided to end its partnership with CrossFit due to a controversial tweet by CrossFit founder and CEO. Yahoo Finance’s Emily McCormick shares the details. …read more […]
Yahoo Finance’s Alexis Christoforous, Brian Sozzi, and Anjalee Khemlani discuss a possible merger between Astrazeneca and Gilead Sciences. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
